Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxis

Autor: Katherine L. Gooch, Johannes G. Liese, Pamela G. Vo, John R. Fullarton, Marcello Lanari, Jean-Bernard Gouyon, Xavier Carbonell-Estrany, José Figueras-Aloy
Přispěvatelé: Neonatology, Hospital Clinic, Centre d'Études Périnatales de l'Océan Indien (CEPOI), Université de La Réunion (UR)-Centre Hospitalier Universitaire de La Réunion (CHU La Réunion), CHU Saint-Pierre, Carbonell-Estrany, Xavier, Fullarton, John R, Gooch, Katherine L, Vo, Pamela G, Figueras-Aloy, Jose, Lanari, Marcello, Gouyon, Jean-Bernard, Liese, Johannes G
Rok vydání: 2013
Předmět:
Parents
Pediatrics
Diseases
Infant
Premature
Diseases

medicine.disease_cause
Cohort Studies
0302 clinical medicine
Risk Factors
Monoclonal
030212 general & internal medicine
Antibiotic prophylaxis
Humanized
Family Characteristics
Obstetrics and Gynecology
Gestational age
3. Good health
Hospitalization
Respiratory syncytial virus (RSV)
Infant
Premature

Family Characteristic
Human
Cohort study
medicine.drug
Palivizumab
medicine.medical_specialty
Gestational Age
Respiratory Syncytial Virus Infections
Antibodies
Monoclonal
Humanized

Antibodies
03 medical and health sciences
030225 pediatrics
antiviral agents
medicine
Antibiotic Prophylaxi
Humans
Risk factor
Premature
Antiviral Agent
Respiratory Syncytial Virus Infection
[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics
business.industry
Risk Factor
Infant
Newborn

Infant
Infant
Premature
Disease

Antibiotic Prophylaxis
Newborn
medicine.disease
Confidence interval
Parent
Bronchiolitis
Pediatrics
Perinatology and Child Health

Tobacco Smoke Pollution
Cohort Studie
business
Zdroj: Journal of Maternal-Fetal and Neonatal Medicine
Journal of Maternal-Fetal and Neonatal Medicine, Taylor & Francis, 2013, 26 (9), pp.926--931. ⟨10.3109/14767058.2013.765850⟩
ISSN: 1476-4954
1476-7058
Popis: International audience; OBJECTIVE: To assess the impact of household smoking and palivizumab prophylaxis on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm (32-35 weeks' gestational age) infants. METHODS: Familial smoking and other RSV risk factor data from the FLIP, FLIP-2 and IMpact studies and datasets from France, Germany and Italy, together with palivizumab prophylaxis data from the FLIP-2 and IMpact studies, were analysed using cross-correlation and Bayesian meta-analytical modelling employing Markov Chain Monte Carlo sampling. RESULTS: There were 2.35 times (95% confidence interval [CI] 1.37-4.02) as many hospitalisations amongst infants from smoking compared with those from non-smoking families. Among non-prophylaxed infants, there were 2.53 times (95% CI 1.27-4.94) as many RSV hospitalisations from smoking than from non-smoking families and that excess hospitalisation was reduced to 1.03 times (95% CI 0.38-2.99) amongst prophylaxed infants. Familial smoking correlates significantly (p \textless 0.01) with other RSV risk factors: positive correlation with number of school-age siblings, history of family atopy, family wheeze and gestational age; negative correlation with birth weight and breast feeding. CONCLUSIONS: Late-preterm infants from smoking families appear to be at heightened risk for severe RSV infection requiring hospitalisation of which the risk may be reduced with RSV prophylaxis.
Databáze: OpenAIRE